GSK Cuts Jobs to Fund £400 Million Cambridge R&D Hub in £1.9 Billion Overhaul
Updated
Updated · The Guardian · Jul 28
GSK Cuts Jobs to Fund £400 Million Cambridge R&D Hub in £1.9 Billion Overhaul
3 articles · Updated · The Guardian · Jul 28
Summary
GSK said it will make sweeping job cuts as part of a £1.9 billion cost-cutting plan while investing £400 million in UK life sciences over the next three years.
More than 1,000 scientists will move to a new R&D centre on the Cambridge biomedical campus, a key step in GSK’s push to speed drug development under its new chief executive.
The reshuffle will shut GSK’s Stevenage R&D site in Hertfordshire by 2029, while laboratories at nearby Ware will be upgraded and some staff relocated there.
The plan signals a broader reorganization of GSK’s UK research footprint, concentrating scientists in Cambridge as the drugmaker seeks faster and more efficient development.